Ticker Details
iTeos Therapeutics, Inc.
IPO Date:	June 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$448.68M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.56 | 2.72%
Avg Daily Range (30 D):	$0.03 | 0.30%
Avg Daily Range (90 D):	$0.05 | 0.46%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	M
Avg Daily Volume (90 D):	.66M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	448
Avg Trade Size (Sh.) (90 D):	158

Institutional Trades
Total Institutional Trades:	1,150
Avg Institutional Trade:	$2.01M
Avg Institutional Trade (30 D):	$6.53M
Avg Institutional Trade (90 D):	$2.07M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.01M
Avg Closing Trade (30 D):	$52.45M
Avg Closing Trade (90 D):	$3.5M
Avg Closing Volume:	103.93K

News

Jul 26, 2025 @ 5:36 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jul 22, 2025 @ 12:39 AM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jul 21, 2025 @ 7:59 PM $HAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde

Jul 21, 2025 @ 11:29 AM iTeos Therapeutics Enters into Agreement to Be Acq... Source: Globe Newswire

Apr 29, 2025 @ 9:47 PM iTeos publie les résultats financiers de son pr... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-4.69	$-1.81	$-.8
Diluted EPS	$-4.69	$-1.81	$-.8
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-202.41M	$-78.73M	$-34.61M
Operating Income / Loss	$-221.94M	$-83.79M	$-40.02M
Cost of Revenue
Net Cash Flow	$-46.92M	$49M	$13.96M
PE Ratio